Status:
COMPLETED
Immunohistochemical Expression of EGFR in the Patients Having Oral Squamous Cell Carcinoma
Lead Sponsor:
Combined Military Hospital, Pakistan
Collaborating Sponsors:
National University of Medical Sciences, Pakistan
Conditions:
Oral Cancer , Oral Squamous Cell Carcinoma, Oral Cavity Cancer
Eligibility:
All Genders
Brief Summary
Oral squamous cell carcinoma (OSCC) is one of the top 10 most common malignancies worldwide. Oral squamous cell carcinoma forms a major health problem in many countries. The reason for the high incide...
Detailed Description
Oral SCC is a type of cancer that develops from the oral epithelium and accounts for more than 90% of all oral malignancies, with a death rate of more than 140,000 cases globally. It is an invading ne...
Eligibility Criteria
Inclusion
- Cases of surgically treated lip/oral cavity squamous cell carcinoma
- Patients of all age groups, irrespective of their gender
- Patients with a tumor located in the tongue, inferior and superior gingivae, buccal mucosa, floor of the mouth, palate, alveolus and vestibule(buccal/labial and mandible/maxilla)
Exclusion
- All specimens with inadequate or poor fixation.
- All specimen of patients having received chemotherapy/radiotherapy prior to surgery
- Very scanty tissue biopsies or those with extensive tissue necrosis
- Patients not consenting to be the part of the study
Key Trial Info
Start Date :
August 26 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 28 2023
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT06606301
Start Date
August 26 2023
End Date
December 28 2023
Last Update
September 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Armed Forces Institute of Pathology, Combined Military Hospital
Rawalpindi, Punjab Province, Pakistan, 46000